Enliven Therapeutics (ELVN) Q3 2021 Earnings

9NovExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-2.96
-2.16
-1.36
-0.56

Details

Expected EPS
-0.8457
Actual EPS
-2.2
Surprise EPS
-1.35
Surprise Percent
+160.14%

Description

Enliven Therapeutics (ELVN) has reported earnings of -2.2 per share for Q3 2021.

0 Comments

Share your thoughts